ARQT
Arcutis Biotherapeutics Inc
26.90$
+2.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -65.1% | +79.4% | +272.1% | +105.7% | +62.8% | +70.9% | +79.6% | |
| – | +459.3% | +445.7% | +864.0% | +200.8% | +36.8% | +18.8% | +7.5% | -3.3% | |
| – | +231.4% | -84.7% | +1,598.9% | +199.2% | +163.6% | – | – | – | |
| – | +655.6% | -171.4% | – | -74.4% | -381.1% | – | – | – | |
| – | +0.0% | +0.0% | +8.8% | +210.0% | +2,240.0% | -98.2% | -66.6% | +379.7% | |
| – | +0.0% | +128.3% | +590.7% | -58.2% | +14.8% | – | -84.0% | -205.0% | |
| – | – | – | – | – | +69.7% | – | – | – | |
| – | +771.3% | +53.4% | -99.3% | +36.5% | +1,380.8% | – | – | – | |
| – | +147,874.0% | +0.0% | +0.0% | -2.2% | +72.8% | -100.0% | – | -100.0% | |
| – | +765.2% | +51.2% | +220.2% | -5.4% | +7.0% | -66.4% | -34.7% | -89.5% | |
| – | +975.8% | -33.5% | -86.3% | +854.0% | -237.5% | – | -150.4% | – | |
| – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.